Acrobiosystems Co

Acrobiosystems Co ROIC

The Return on Invested Capital (ROIC) of Acrobiosystems Co (301080.SZ) as of Nov 11, 2026 is 6.10 %. In the previous year, Return on Invested Capital (ROIC) was 4.73 % — a change of 28.91% (higher).

ROIC

6.10 %

YoY

28.91%

Last updated:

Return on Invested Capital (ROIC) of Acrobiosystems Co is 2025 6.10 % . Return on Invested Capital (ROIC) of Acrobiosystems Co was 2024 4.73 % . It decreases by 28.91% higher compared to the previous year.

The Acrobiosystems Co ROIC history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROIC
Date
ROIC
Jan 1, 2018
15.47 CNY
Jan 1, 2019
11.40 CNY
Jan 1, 2020
57.85 CNY
Jan 1, 2021
7.06 CNY
Jan 1, 2022
7.95 CNY
Jan 1, 2023
5.93 CNY
Jan 1, 2024
4.73 CNY
Jan 1, 2025
6.10 CNY
The Acrobiosystems Co ROIC history
YEARROICYoY
6.10 %+28.91%
4.73 %-20.18%
5.93 %-25.38%
7.95 %+12.55%
7.06 %-87.79%
57.85 %+407.50%
11.40 %-26.31%
15.47 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Acrobiosystems Co Stock analysis

What does Acrobiosystems Co do? Acrobiosystems Co Ltd develops biomedicine and bio-protein technology, focusing on recombinant proteins, detection services, kits, antibodies, fillers, and culture media. The company serves R&D and production sectors for drug discovery, screening, diagnostic reagents, and clinical trials across tumor, autoimmune, cardiovascular, and infectious disease areas. Its products support early drug development stages and process control in pharmaceutical manufacturing. The firm's main customers are pharmaceutical companies and research institutions requiring advanced biotech solutions for disease treatment development. The company generates revenue through the sale of recombinant proteins, detection services, and related products like kits and antibodies. These offerings are tailored for pharmaceutical firms engaged in drug development and diagnostic reagent optimization. Acrobiosystems' product portfolio targets the biopharmaceutical industry, specifically addressing needs in tumor, autoimmune, cardiovascular, and infectious disease research. The firm's services are utilized in preclinical and clinical trial phases to enhance drug development efficiency. Acrobiosystems' main products include recombinant proteins, kits, antibodies, fillers, and culture media, which are sold to pharmaceutical companies and research organizations. These entities use the products for early-stage drug discovery, verification, and optimization processes. The company's detection services support diagnostic reagent development and drug screening, directly contributing to the pharmaceutical R&D pipeline. The firm's focus on CMC (process control) for drug production ensures its offerings align with critical manufacturing stages in biopharmaceutical development. Acrobiosystems Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Acrobiosystems Co stock

Return on Invested Capital (ROIC) of Acrobiosystems Co is 6.10 % in 2025.

Return on Invested Capital (ROIC) of Acrobiosystems Co changed from 4.73 % to 6.10 %, representing a 28.91% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Invested Capital (ROIC) Acrobiosystems Co since 2006 – with annual values, charts, and detailed analysis.

ROIC measures how effectively a company uses its invested capital to generate profits. A ROIC above the cost of capital creates shareholder value.

ROIC = NOPAT / Invested Capital

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Invested Capital (ROIC)'s Acrobiosystems Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Invested Capital (ROIC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Invested Capital (ROIC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Acrobiosystems Co

All Key Metrics — Acrobiosystems Co